top of page

OncoVerity

More About the Company

Status:

Technology Type:

Active

Pharma

Fund:

Fund I, Fund II

CU Anschutz Medical Campus Spinout:

Yes

Headquarters 
Location:

Aurora, CO, USA

Data Driven AML Treatment

OncoVerity is the fourth spin-off company from argenx's Immunology Innovation Program developed in collaboration with CU Anschutz and UCHealth. The company is working to advance treatments for AML based novel data-driven translational biology insights.


OncoVerity is a CU Anschutz spinout company.

bottom of page